Skip to main content
ENDO 2026 Main banner

Irene Netchine, MD,PhD

Hopital Trousseau
Saint Mande, FRANCE

Irène Netchine is professor of physiology at Sorbonne Université, Armand Trousseau Children's Hospital, Paris, France. Her initial training was in paediatric endocrinology after which she obtained her PhD in human genetics at University Paris Est Creteil (UPEC), France.
She is coordinating a department of Paediatric Endocrinology and a clinical center of reference for rare endocrine anomalies of growth and development and a molecular diagnosis laboratory (concerning growth retardation and excessive growth) and is leader of an INSERM-Sorbonne Université research team « Pathopysiology of Foetal Growth: IGF system and parental imprinting, https://en.crsa.fr/team-irene-netchine.html» since 2012 at the CRSA, Paris France. Her initial research interests were in the field of the genetics of growth hormone deficiency and the molecular pathology of anterior pituitary development. Her current research focus is the implication of the insulin-like growth factor (IGF) system in intra-uterine growth retardation and imprinting anomalies leading to foetal growth disorders. She has developed a multidisciplinary clinic for patients with Silver Russell and Beckwith Wiedemann Syndrome and has been the chair of the two 2 first Silver Russell Syndrome international consensus. She received the prestigious European Society of Pedaitric Endocrinology (ESPE) research award in 2019 and the Robert Blizzard prize from the Human Growth Foundation in 2024.
She is the president of the scientific council of the French Society for Pediatric Endocrinology and Diabetology since 2021. She has been the principal investigator in the last 5 years of numerous grants among which 2 French ANR projects, one ESPE collaborative grant in 2024, one Pfizer Aspire Grant in 2018 and one international Grant for Growth Innovation in 2017 from Merk Serono.

Disclosure information not submitted.

Presentation(s):